Helix BioPharma Corp.: Helix Biopharma Corp. Announces Exten

RICHMOND, ON / ACCESSWIRE / April 13, 2022 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology

Related Keywords

Canada , Toronto , Ontario , Richmond Hill , Canadian , Frank Michalargias , Toronto Stock Exchange , Helix Biopharma Corp , Incentive Program , Helix Biopharma , Early Warrant Exercise Incentive Program , Eligible Warrants , Incentive Exercise Price , Extended Warrants , Warrant Extension , Anne Mitchell , Grove Issuer Services , Jerzy Wilczewski , Chief Financial , Looking Statements , Annual Information Form , Helix , Iopharma , Orp , Nnounces , Extension , Early , Warrant , Exercise , Incentive , Program , Receipt , Private , Placement , Subscription ,